Antibacterial Agents TRIZ Cases

EDTA chelates metal ions to disrupt biofilms, enabling lower antiseptic concentrations that reduce cell toxicity while maintaining antimicrobial activity.

A nucleophilic addition to an iminocetene intermediate produces azetidinimines with enhanced antibiotic properties.

A multi-layer cellulosic substrate adhered by a cationic adhesive composition prevents electrostatic deactivation of biocides during storage.

Thiolic ligands coordinate silver ions to prevent light-induced neutralization and sustain antimicrobial activity.

A polypeptide with dual effector domains simultaneously blocks C3 and C5 convertase activity.

Optimizing Teicoplanin A2 and A3 ratios resolves the trade-off between production cost and antibiotic activity, achieving higher efficacy.

Elastomeric particles embedded in a fibrin matrix provide superior mechanical stability and controlled bioactive release for soft tissue void filling.

Segmented antibody design eliminates pro-inflammatory cytotoxicity from TNFR1 crosslinking while maintaining neutralizing efficacy and prolonged half-life.

Engineering hypervariable loops on fibronectin type III scaffolds resolves the trade-off between target affinity and molecular weight.

Lactobacillus parafarraginis strain Lp18 inhibits fungal and bacterial pathogens in plants through direct application or soil treatment.

Engineered ClyO lysin hydrolyzes peptidoglycan cell walls to release intracellular ATP and DNA, enabling rapid detection of methicillin-resistant strains.

Fusing SMR and CPP domains creates peptides that penetrate and dismantle microbial biofilms, overcoming bacterial resistance mechanisms.

Novel RND efflux pump inhibitors block bacterial transport mechanisms to potentiate antibiotic activity against resistant pathogens.

Hyr1 polypeptide fragments elicit targeted immune responses, reducing toxicity while maintaining microbial killing effectiveness.

Formula I boronic acid compounds inhibit metallo-beta-lactamases, restoring beta-lactam antibiotic efficacy against multidrug-resistant bacteria.

Formula I and A-I compounds bind beta-lactamases to overcome resistance in KPC and class D strains.

Synergistic taurolidine and protamine coatings prevent bacterial colonization while reducing toxicity risks associated with high-dose conventional agents.

Monoclonal antibodies bind Staphylococcus aureus leukotoxins to neutralize virulence factors and prevent cell lysis.

Administering manganese induces GPP130 degradation, blocking Shiga toxin trafficking and enabling safe antibiotic therapy.

TIGIT polypeptides modulate T cell activity through PVR interaction, addressing the lack of specific targeting in existing autoimmune therapies.

Peripheral modifications on pocket-redesigned vancomycin analogs add a second mechanism of action that overcomes rapid bacterial resistance development.

A chloroquine nanosphere gel delivers sustained drug release via a water-soluble chitosan carrier.

Removing restriction sites from bacteriophage genomes expands host range and delivery efficiency while preserving microbiome diversity.

Amphotericin B derivatives modify C16 and N positions to selectively bind ergosterol, reducing toxicity without compromising antifungal efficacy.

Gamma-irradiation inactivates whole-cell bacteria while preserving antigenic structures, preventing serotype replacement without reversion risks.

pH-responsive lipid assemblies switch charge states to improve transfection efficiency while reducing toxicity.

Fused heteroaryl pyridyl sulfonamides modulate chemokine receptor activity through sustained-release prodrug formulations.

A one-handed dental fluid applicator uses a displacement piston to expel liquid from a sealed container.

Virus-like particles present Staphylococcus aureus autoinducing peptide epitopes to limit agr-activation and reduce bacterial burden in dermonecrosis models.

Disc-shaped particles with lipid binding polypeptides stabilize hydrophobic agents in aqueous media, resolving solubility and stability contradictions.

Cationic porphyrin compounds disrupt microbial biofilms via electrostatic attraction, overcoming antibiotic resistance while sparing mammalian cells.

Biodegradable particles with controlled size and composition differentiate Th1 and Th2 cell responses to enhance animal survival rates.

Deleting hya genes prevents Salmonella from using hydrogen gas, reducing virulence while maintaining immunogenicity.

Catalytic hydrogenation converts biological feedstock into isoparaffin oil, resolving oxidation instability in pharmaceutical formulations.

Preliminary chirality introduction during enolate formation yields high purity aminosulfones while avoiding costly separation steps.

Computational screening identifies host-targeted compounds that inhibit viral entry and reduce hyperinflammatory responses.

Robenidine combinations overcome multi-drug resistance by targeting Gram-positive and Gram-negative bacteria through segmented action mechanisms.

Hydrophobically modified chitosan foam expands via propellant to fill irregular wound cavities and adhere to tissue surfaces.

Fully native human monoclonal antibodies neutralize tetanus toxin with high affinity and specificity.

N3′→P5′ phosphorodiamidate linkages replace phosphodiester bonds in antisense oligonucleotides, resolving nuclease degradation and poor membrane permeability.

Pyrrolo[2,3-d]pyrimidin-2-one compounds bind bacterial ribosomes to inhibit protein synthesis and treat resistant microbial infections.

Ethanol extract of propolis coating enhances catheter hydrophilicity and reduces bacterial adhesion.

Lipopolysaccharide adjuvant in oil-in-water vaccine formulation resolves weak cellular immunity by stimulating balanced Th1/Th2 response.

Arginine-rich carrier peptides conjugate with antisense oligonucleotides to bypass antibiotic resistance mechanisms by blocking essential mRNA translation.

Synthetic saccharide structures conjugated to immunogenic carriers stimulate effective immune responses in infants and young children.

Amino acid modifications in somatostatin analogs increase blood stability without losing affinity for sstr1 to sstr5 receptors.

Storing saponin liposomes for 4 to 24 hours improves filterability and prevents clogging during sterile filtration.